Ramon Bellfill-Lleonart

Barcelona, CT, Spain

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications

Acquired Hemophilia A Following Omalizumab Treatment in a Patient With Chronic Spontaneous Urticaria.

Acquired Hemophilia A Following Omalizumab Treatment in a Patient With Chronic Spontaneous Urticaria.

Journal: Journal of investigational allergology & clinical immunology
Published: December 09, 2025

Acquired Hemophilia A Following Omalizumab Treatment in a Patient With Chronic Spontaneous Urticaria.

Acquired Hemophilia A Following Omalizumab Treatment in a Patient With Chronic Spontaneous Urticaria.

Journal: Journal of investigational allergology & clinical immunology
Published: December 09, 2025

Hypersensitivity to Bismuth Subcitrate.

Hypersensitivity to Bismuth Subcitrate.

Journal: Journal of investigational allergology & clinical immunology
Published: September 05, 2024

Expert Review and Consensus on the Treat-to-Target Management of Hereditary Angioedema: From Scientific Evidence to Clinical Practice.

Expert Review and Consensus on the Treat-to-Target Management of Hereditary Angioedema: From Scientific Evidence to Clinical Practice.

Journal: Journal of investigational allergology & clinical immunology
Published: February 22, 2023

Are antihistamines still used during omalizumab treatment for chronic spontaneous urticaria?

Are antihistamines still used during omalizumab treatment for chronic spontaneous urticaria?

Journal: European journal of dermatology : EJD
Published: December 05, 2022

A Pilot Experience Using a 1-Bag Intravenous Rapid Desensitization Protocol for Chemotherapy and Biologics in a Cohort of Patients With Access to a Delabeling Pathway.

A Pilot Experience Using a 1-Bag Intravenous Rapid Desensitization Protocol for Chemotherapy and Biologics in a Cohort of Patients With Access to a Delabeling Pathway.

Journal: Journal of investigational allergology & clinical immunology
Published: September 28, 2022

Medical algorithm: Diagnosis and treatment of hypersensitivity reactions to cancer chemotherapy.

Medical algorithm: Diagnosis and treatment of hypersensitivity reactions to cancer chemotherapy.

Journal: Allergy
Published: January 31, 2021

Delabeling patients from chemotherapy and biologics allergy: Implementing drug provocation testing.

Delabeling patients from chemotherapy and biologics allergy: Implementing drug provocation testing.

Journal: The journal of allergy and clinical immunology. In practice
Published: August 07, 2020

Treating COVID-19: Review of Drug Hypersensitivity Reactions.

Treating COVID-19: Review of Drug Hypersensitivity Reactions.

Journal: Journal of investigational allergology & clinical immunology
Published: July 24, 2020

Pilot Experience Using Drug Provocation Testing for the Study of Hypersensitivity to Chemotherapy and Biological Agents.

Pilot Experience Using Drug Provocation Testing for the Study of Hypersensitivity to Chemotherapy and Biological Agents.

Journal: Journal of investigational allergology & clinical immunology
Published: June 24, 2020

Adverse reactions of drugs specifically used for treatment of SARS-CoV-2 infection

Adverse reactions of drugs specifically used for treatment of SARS-CoV-2 infection

Journal: Medicina clinica
Published: May 02, 2020

Adverse reactions of drugs specifically used for treatment of SARS-CoV-2 infection.

Adverse reactions of drugs specifically used for treatment of SARS-CoV-2 infection.

Journal: Medicina clinica (English ed.)
Published: May 02, 2020
Showing 1-12 of 13

Last Updated: 09/26/2026